ORCID
0000-0001-5947-4778 (Yehya)
Document Type
Article
Publication Date
2025
DOI
10.15420/usc.2025.03
Publication Title
US Cardiology Review
Volume
19
Pages
e19
Abstract
Heart failure (HF) is a clinical syndrome characterized by signs and symptoms resulting from any structural or functional deficiency of ventricular filling or blood ejection. The mainstay of initial treatment remains lifestyle modifications, guideline-directed medical therapy, and addressing contributing factors. However, the past two decades have come with significant advances in device therapies to improve morbidity and mortality in HF despite evidence-based management as above. Given the rapidly evolving area of HF research and therapeutic development, it is important for clinicians to be familiar with novel therapies and how they can complement medical management. In this review we discuss the current landscape of novel non-surgical device therapies in HF, their respective trials, major outcomes, and their mechanisms of action and target pathways.
Rights
© 2025 The Authors.
This work is open access and is licensed under Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC 4.0) License. Users may copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.
Original Publication Citation
Benarroch, Y., Tapaskar, N., & Yehya, A. (2025). Role of device therapy in complementing contemporary medical management. US Cardiology Review, 19, Article e19. https://doi.org/10.15420/usc.2025.03
Repository Citation
Benarroch, Y., Tapaskar, N., & Yehya, A. (2025). Role of device therapy in complementing contemporary medical management. US Cardiology Review, 19, Article e19. https://doi.org/10.15420/usc.2025.03
Supplementary Material